Ad5-Vectored COVID-19 Vaccine Immunogenic in Healthy Adults

THURSDAY, July 23, 2020 -- The nonreplicating adenovirus type-5 (Ad5)-vectored COVID-19 vaccine appears safe and induces immune responses at a dose of 5 ×1010 viral particles, according to a study published online July 20 in The Lancet. Feng-Cai...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news